These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 25787989)
21. Slum upgrading strategies involving physical environment and infrastructure interventions and their effects on health and socio-economic outcomes. Turley R; Saith R; Bhan N; Rehfuess E; Carter B Cochrane Database Syst Rev; 2013 Jan; (1):CD010067. PubMed ID: 23440845 [TBL] [Abstract][Full Text] [Related]
22. [Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions]. Furman-Assaf S; Tamir O; Marom E; Arieli M; Shemer J Harefuah; 2010 Jul; 149(7):470-5, 479. PubMed ID: 21465764 [TBL] [Abstract][Full Text] [Related]
23. Understanding and fighting the medicine counterfeit market. Dégardin K; Roggo Y; Margot P J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475 [TBL] [Abstract][Full Text] [Related]
24. Lifestyle intervention for improving school achievement in overweight or obese children and adolescents. Martin A; Saunders DH; Shenkin SD; Sproule J Cochrane Database Syst Rev; 2014 Mar; (3):CD009728. PubMed ID: 24627300 [TBL] [Abstract][Full Text] [Related]
25. Online pharmacy still open despite counterfeit allegations. Vogel L CMAJ; 2017 Aug; 189(31):E1023-E1024. PubMed ID: 28790061 [No Abstract] [Full Text] [Related]
27. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures. Kumar B; Baldi A Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250 [TBL] [Abstract][Full Text] [Related]
28. Materials and Technologies to Combat Counterfeiting of Pharmaceuticals: Current and Future Problem Tackling. Zhang H; Hua D; Huang C; Samal SK; Xiong R; Sauvage F; Braeckmans K; Remaut K; De Smedt SC Adv Mater; 2020 Mar; 32(11):e1905486. PubMed ID: 32009266 [TBL] [Abstract][Full Text] [Related]
29. Counterfeit drugs: an Australian perspective. Hensey CC; Gwee A Med J Aust; 2016 May; 204(9):344. PubMed ID: 27169964 [No Abstract] [Full Text] [Related]
31. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law. Olliaro E; Olliaro P; Ho CWL; Ravinetto R Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313 [TBL] [Abstract][Full Text] [Related]
32. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey. Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046 [TBL] [Abstract][Full Text] [Related]
33. The silent development of counterfeit medications in developing countries - A systematic review of detection technologies. Bolla AS; Patel AR; Priefer R Int J Pharm; 2020 Sep; 587():119702. PubMed ID: 32736015 [TBL] [Abstract][Full Text] [Related]
34. Counterfeit medicines in Peru: a retrospective review (1997-2014). Medina E; Bel E; Suñé JM BMJ Open; 2016 Apr; 6(4):e010387. PubMed ID: 27044580 [TBL] [Abstract][Full Text] [Related]